Clinical trial
Incidence, Risk Factor, Treatment and Overall Survival of Locoregionally Recurrent Colon Cancer: a Retrospective, Population-based Cohort Study
NCT05475288 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Incidence, Risk Factor, Treatment and Overall Survival of Locoregionally Recurrent Colon Cancer: a Retrospective, Population-based Cohort Study
- Lead sponsor
- Radboud University Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2015
- Completion date
- June 30, 2015
- Enrollment
- 3,554 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.